Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Speaking on Sunday with Laura Kuenssberg, Streeting said the jabs were part of a broader healthcare plan, adding that he was ...
For 14 years, Jesse’s mind spiraled. So did his weight. The medications he took for schizophrenia drove his weight up until ...
A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect ...
Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...
Ozempic can cause inflammation of the pancreas, a potentially life-threatening condition. Symptoms include severe stomach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback